WinstonWınston
Nexteligent Holdings logo

Nexteligent Holdings

NXGT
31
Medical - Care Facilities · Healthcare
Price
$0.01
+0.00 (+0.00%)
Market Cap
$240,406
Winston Score
31
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+80.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 69.7M (2021) → 125.8M (2025)

Nexteligent Holdings, Inc. is a small healthcare company operating in the medical care facilities industry. It focuses on providing healthcare-related services, likely including managed care or technology-enabled health services, to patients and healthcare organizations. The company operates in a sector that connects patients with medical care and administrative support.

Nexteligent generates revenue through service fees tied to healthcare delivery or management contracts rather than selling physical products. It appears to be a very small company, given its near-zero market capitalization, and has not yet reached meaningful profitability, as shown by its negative operating margin. The main risk facing the business is its early-stage financial profile — with essentially no gross profit and a tiny scale, it must grow revenue significantly or cut costs to become a sustainable operation.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-14.4% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+133.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

47.2%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$0 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Nexteligent Holdings has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
0.0%
Thin — 0.0% gross margin
Operating Margin
8.3%
Modest — 8.3% operating margin
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+19.1%
Fast-growing sales (19.1% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-20.0%
Burning cash (-20.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
0.01x
Dangerous — barely covers interest (0.0x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
21.7x
Growth-priced — P/E 21.7

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial